ESC 365 - undefined undefined undefined

Speaker illustration

undefined undefined undefined

Presentations Articles

Resolution of systemic inflammation in patients with recently decompensated heart failure with reduced ejection fraction with and without interleukin-1 blockade by anakinra

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Biomarkers and prognosis in acute heart failure

Diabetes mellitus and response to IL-1 blockade with Anakinra after ST-elevation myocardial infarction: a pooled analysis of the VCU-ART studies

Event: ESC Congress 2023

Topic: Inflammation and Immunity

Session: Diabetes and stable coronary artery disease

Interleukin -1 inhibitors.

Event: Heart Failure 2020

Topic: Basic Science

Session: Lessons from recent and ongoing heart failure trials

Interleukin-1 blockade with Anakinra in ST-segment elevation acute myocardial infarction: Results from the VCUART3 study

Event: ESC Congress 2019

Topic: Pharmacotherapy

Session: Emerging treatments in acute coronary syndromes

Effects of Interleukin-1 blockade with Anakinra on cardiac function in ST-segment elevation acute myocardial infarction: results from the VCUART3 echocardiography study

Event: ESC Congress 2019

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: New insights for acute coronary syndrome pharmacotherapy

ESC 365 is supported by

novartis

Explore sponsored resources